Splenic histiocyte-rich pseudotumor following chemotherapy for non Hodgkin diffuse large B cell lymphoma
Abdou, A.G.; Kandil, M.; Eldien, M.S.; Abdallah, R.
Pathologica 108(3): 140-143
2016
ISSN/ISBN: 0031-2983 PMID: 28195266 Document Number: 687487
Chemotherapy may induce mass lesion in rare conditions, which can be easily mistaken as a residual tumor mass. In this report, we describe a mass affecting spleen in a patient received chemotherapy for non Hodgkin diffuse large B cell lymphoma. This mass proved histologically to be non neoplastic formed of sheets of histiocytes and xanthoma cells, which is called histiocyte-rich pseudotumor. This report describes this rare lesion and the possible differential diagnosis.
Document emailed within 1 workday
Related Documents
Barut, F.; Kandemir, N.O.; Gun, B.D.; Ozdamar, S.O. 2016: T-cell/histiocyte-rich large B-cell lymphoma of stomach JPMA. Journal of the Pakistan Medical Association 66(7): 905-907Nesterova, E.S.; Mangasarova, I.K.; Bariakh, E.A.; Gubkin, A.V.; Tolstykh, T.N.; Lukina, A.I.; Kovrigina, A.M.; Domracheva, E.V.; Chernova, N.G.; Mar'in, D.S.; Zvonkov, E.E.; Gemdzhian, É G.; Kravchenko, S.K. 2014: Experience with high-dose chemotherapy in patients with testicular diffuse large B-cell lymphoma Terapevticheskii Arkhiv 86(7): 59-67
Montalbán, C.; Arechaga, S.; Calleja, J.L.; Bellas, C.; Patier, J.L.; Berenguer, A.; García Villanueva, A.; Marcos Robles, J. 1990: Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy Medicina Clinica 94(12): 461-464
Martinka, M.; Comeau, T.; Foyle, A.; Anderson, D.; Greer, W. 1997: Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma Clinical and Investigative Medicine 20(6): 364-370
Acabá, L.; Santiago, N.; Vélez García, E. 1996: T-cell rich B-cell lymphoma masquerading as Hodgkin disease: excellent outcome to inadequate therapy Boletin de la Asociacion Medica de Puerto Rico 88(4-6): 32-34
Marafioti, T.; Mancini, C.; Ascani, S.; Sabattini, E.; Zinzani, P.Luigi.; Pozzobon, M.; Pulford, K.; Falini, B.; Jaffe, E.S.; Müller-Hermelink, H-Konrad.; Mason, D.Y.; Pileri, S.A. 2004: Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease Haematologica 89(8): 957-964
Chubachi, A.; Miura, A.B.; Takatsu, H.; Yamaguchi, A.; Nishimura, S.; Nakayama, Y.; Akihama, T.; Miura, S.; Saitoh, M.; Watanuki, T. 1991: Clinical significance of immunophenotype in diffuse non-Hodgkin's lymphoma: with special emphasis on the clinical characteristics of T-cell lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(8): 1303-1309
Sharma, V.; Gupta, S.; Patel, M.; Dora, T.; Sancheti, S. 2018: Diffuse Large B Cell Lymphoma of Larynx Journal of the Association of Physicians of India 66(5): 91-93
Kawakami, K.; Amakawa, R.; Miyanishi, S.; Okumura, A.; Hayashi, T.; Kurata, M.; Ohno, H.; Ohno, Y.; Fukuhara, S. 1998: A case of primary splenic large cell lymphoma with a t(9;14)(p13;q32) International Journal of Hematology 67(2): 191-198
Ding, C.; Li, T.ü; Sun, J.; Yang, W.; Ding, Q.; Xu, X. 2014: Prognostic value of PET-CT in patients with diffuse large B-cell lymphoma Zhonghua Zhong Liu Za Zhi 36(12): 923-927
Bonnet, C.; De Prijck, B.; Lejeune, M.; Fassotte, M.-F.; Van Den Neste, E.; Beguin, Y. 2012: Diffuse large B cell lymphoma: management in 2012 Revue Medicale Suisse 8(351): 1582-1584; 1586-1590
Kreuziger, L.M.B.; Morrison, V.A. 2011: Late relapses in diffuse large B-cell lymphoma Clinical Advances in Hematology and Oncology: H&o 9(9): 709-710
Straus, D.J.; Wong, G.; Yahalom, J.; Varsos, G.; Gulati, S.; Clarkson, B. 1991: Diffuse large cell lymphoma. Prognostic factors with treatment Leukemia 5(Suppl): 32-37
Prabhash, K.; Biswas, G.; Nair, R.; Pandey, D.; Maru, D.; Mahajan, A.; Parikh, P.M. 2006: Metachronous gastric diffuse large B-cell lymphoma and adenocarcinoma Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(5): 261-262
Inagaki, H.; Banno, S.; Wakita, A.; Ueda, R.; Eimoto, T. 1999: Prognostic significance of CD44v6 in diffuse large B-cell lymphoma Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 12(5): 546-552
Yang, J.P.; Hu, C.M.; Zhong, W.; Wang, Z.G. 2017: Primary diffuse large B-cell lymphoma of the frontal sinus Journal of Biological Regulators and Homeostatic Agents 31(2): 447-451
Marks, D.I.; Sheridan, W.P.; Ellis, D.W.; Boyd, A.W.; Morstyn, G.; Green, M.D.; Fox, R.M. 1989: Diffuse large cell lymphoma: a teaching hospital experience Australian and New Zealand Journal of Medicine 19(2): 159-161
Papajik, T.; Raida, L.; Faber, E.; Vondrakova, J.; Prochazka, V.; Kubova, Z.; Skoumalova, I.; Jarosova, M.; M, L.K.; Paucek, B.; Myslivecek, M.; Neoral, C.; Oral, I.; Jarkovsky, J.; Dusek, L.; Indrak, K. 2008: High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission Neoplasma 55(3): 215-221
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Lamendola, M.Gaetana.; Ferraraccio, F.; Pane, U.; De Luca, G.; D'Armiento, M.; Autorino, R. 2007: Primary diffuse large B-cell lymphoma of the testis: a case-report Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 79(1): 33-35